BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22369448)

  • 1. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z; Cui N; Qin M; Wu X
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma.
    Matsumoto K; Onoyama T; Kawata S; Takeda Y; Harada K; Ikebuchi Y; Ueki M; Miura N; Yashima K; Koda M; Sakamoto T; Endo M; Horie Y; Murawaki Y
    Intern Med; 2014; 53(7):651-4. PubMed ID: 24694471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
    Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
    World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
    Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
    Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus.
    Liu XF; Zou SQ; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):285-9. PubMed ID: 14599986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.
    Hsing AW; Zhang M; Rashid A; McGlynn KA; Wang BS; Niwa S; Ortiz-Conde BA; Goedert JJ; Fraumeni JF; O'Brien TR; Gao YT
    Int J Cancer; 2008 Apr; 122(8):1849-53. PubMed ID: 18076042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population.
    Wu Y; Wang T; Ye S; Zhao R; Bai X; Wu Y; Abe K; Jin X
    Hum Pathol; 2012 Jan; 43(1):56-61. PubMed ID: 21777950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of hilar cholangiocarcinoma and infection of hepatitis virus].
    Liu X; Zou S; Qiu F
    Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):420-2. PubMed ID: 12139797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The retrospective analysis of HBV and HCV infection in cholangiocarcinoma].
    Zou SQ; Liu XF; Guo RX; Li CL; Zhou XS; Zhu XG; Huang ZQ
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):417-9. PubMed ID: 12895347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
    Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
    Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.
    Li Y; Wang H; Li D; Hu J; Wang H; Zhou D; Li Q; Jiang X; Zhou H; Hu H
    J Clin Gastroenterol; 2014; 48(10):878-82. PubMed ID: 24356457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
    Lee BS; Park EC; Park SW; Nam CM; Roh J
    World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
    Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.